Market
Mizuho lifts AvroBio Inc [AVRO] price estimate. Who else is bullish?
AvroBio Inc [NASDAQ: AVRO] closed the trading session at $1.15. The company report on January 30, 2024 at 8:00 AM that AVROBIO and Tectonic Therapeutic Announce Merger. Combined company to be Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Tectonic’s novel GPCR-targeted therapeutic proteins. $130.7 million
